Loading…
Nuwellis, Inc. is projected to rise to $1.12 by 2027, a +47% move from its current price of $0.7577. NUWE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.722 | $0.759 | $0.7978 | +0.17% |
| May 30 | $0.7085 | $0.7603 | $0.8159 | +0.34% |
| May 31 | $0.6985 | $0.7616 | $0.8303 | +0.51% |
| Jun 1 | $0.6904 | $0.7629 | $0.8429 | +0.68% |
| Jun 2 | $0.6835 | $0.7642 | $0.8544 | +0.85% |
| Jun 3 | $0.6774 | $0.7655 | $0.865 | +1.02% |
| Jun 4 | $0.6719 | $0.7667 | $0.875 | +1.19% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6719 | $0.7667 | $0.875 | +1.19% |
| Week 2 | $0.6437 | $0.7759 | $0.9352 | +2.40% |
| Week 3 | $0.6247 | $0.7852 | $0.9869 | +3.63% |
| Week 4 | $0.6101 | $0.7946 | $1.03 | +4.86% |
| Week 5 | $0.5985 | $0.804 | $1.08 | +6.12% |
| Week 6 | $0.5888 | $0.8136 | $1.12 | +7.38% |
| Week 7 | $0.5806 | $0.8234 | $1.17 | +8.67% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Nuwellis, Inc. is a medical device company that develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. It provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure.
The Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through specialty healthcare distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc.
and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Nuwellis, Inc. (NUWE) is currently trading at $0.7577 with a market capitalization of $2.03M and is ranked 5407 by market cap. The stock's current price sits near its ongoing price level and the market position is relatively small in size.
The forecasted price path for NUWE shows a neutral entry in 2026 at $0.7577, rising to a max of $1.15 in that year, with further bullish movement in subsequent years. By 2027 the average price is projected to $1.12, and long-range outlooks extend to a 2050 average of $2.14 with a max of $4.93, signaling multi-year upside potential alongside varying risk.
A major floor 41.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.3% away) — a key level to hold.
The nearest ceiling, 62.3% above — a clean break opens room to run.
A major ceiling 453.0% above — clearing it would confirm fresh momentum.
Key NUWE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NUWE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.942 | Sell | $0.9069 | Sell |
| MA 10 | $0.972 | Sell | $0.959 | Sell |
| MA 20 | $1.03 | Sell | $1.01 | Sell |
| MA 50 | $1.08 | Sell | $1.18 | Sell |
| MA 100 | $1.60 | Sell | $1.96 | Sell |
| MA 200 | $2.51 | Sell | $34.82 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 22.63 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -298.07 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -30.28 | Sell |
| Bollinger %B (20,2) | -0.31 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.61 | Sell |
| Awesome (5,34) | -0.14 | Sell |
| Ultimate (7,14,28) | 18.54 | Buy |
| Momentum (10) | -0.27 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 0.91 | Sell |
| ADX (14) | 27.29 | Sell |
| ATR (14) | 0.04 | Info |
The 30-day technical picture shows a neutral sentiment with an RSI of 20. The short-term movement follows a path between the SMA50 at $1.08 and the SMA200 at $2.51, indicating near-term price activity that may trend toward the $1.08 level before challenging higher levels. The current support is placed at $0.76 and resistance at $1.23, framing a modest trading range in the near term.
The 30-day price range spans from $0.5453 to $1.05, highlighting recent volatility and ceiling pressures within a narrow band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.7577 | $0.7577 | $1.15 | 0% | Neutral | |
| $0.8145 | $1.12 | $1.65 | +47% | Bullish | |
| $0.7441 | $1.08 | $1.69 | +42% | Bullish | |
| $0.6937 | $1.05 | $1.73 | +39% | Bullish | |
| $0.5829 | $0.9231 | $1.57 | +22% | Bullish | |
| $0.513 | $0.8455 | $1.49 | +12% | Neutral | |
| $0.6198 | $1.06 | $1.92 | +40% | Bullish | |
| $0.7313 | $1.30 | $2.42 | +71% | Bullish | |
| $0.7342 | $1.35 | $2.57 | +78% | Bullish | |
| $0.6692 | $1.27 | $2.48 | +68% | Bullish | |
| $0.8693 | $1.93 | $4.12 | +155% | Bullish | |
| $0.965 | $2.14 | $4.93 | +183% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.7577 | $0.7577 | $0.9091 | +0.00% |
| June 2026 | $0.7175 | $0.858 | $1.06 | +13.24% |
| July 2026 | $0.7281 | $0.8845 | $1.12 | +3.08% |
| August 2026 | $0.7014 | $0.8627 | $1.11 | -2.46% |
| September 2026 | $0.7249 | $0.9008 | $1.18 | +4.42% |
| October 2026 | $0.7436 | $0.9328 | $1.24 | +3.56% |
| November 2026 | $0.6952 | $0.8795 | $1.18 | -5.72% |
| December 2026 | $0.6652 | $0.8484 | $1.15 | -3.53% |
Click any year to see its month-by-month NUWE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NUWE is projected to trade between $0.7577 and $1.15, averaging $0.7577 — a potential gain of 0% from today's $0.7577. Price action looks broadly range-bound.
Nuwellis, Inc.'s 2027 outlook centres on $1.12, within a $0.8145 to $1.65 range. That is up +47% on the projected 2026 average. That marks a +47% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, NUWE could reach as high as $1.69, with a base case around $1.08 and support toward $0.7441 — roughly +42% from $0.7577. Momentum favours further upside here.
Expect NUWE to range from $0.6937 to $1.73 through 2029. The $1.05 average target implies a +39% move from current prices. That is -2% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
The NUWE price prediction for 2030 points to an average of $0.9231 (low $0.5829, high $1.57) — a potential gain of +22% on today's $0.7577. Momentum favours further upside here.
In 2031, NUWE is projected to trade between $0.513 and $1.49, averaging $0.8455 — a potential gain of +12% from today's $0.7577. That is -8% versus the projected 2030 average. A consolidation phase looks the most probable path here.
Nuwellis, Inc.'s 2032 outlook centres on $1.06, within a $0.6198 to $1.92 range. That is up +25% on the projected 2031 average. That marks a +40% change versus current levels. Momentum favours further upside here.
By 2033, NUWE could reach as high as $2.42, with a base case around $1.30 and support toward $0.7313 — roughly +71% from $0.7577. Buyers look set to stay in control over this stretch.
Expect NUWE to range from $0.7342 to $2.57 through 2034. The $1.35 average target implies a +78% move from current prices. That is up +4% on the projected 2033 average. Momentum favours further upside here.
The NUWE price prediction for 2035 points to an average of $1.27 (low $0.6692, high $2.48) — a potential gain of +68% on today's $0.7577. Buyers look set to stay in control over this stretch.
In 2040, NUWE is projected to trade between $0.8693 and $4.12, averaging $1.93 — a potential gain of +155% from today's $0.7577. That is up +52% on the projected 2035 average. Momentum favours further upside here.
Nuwellis, Inc.'s 2050 outlook centres on $2.14, within a $0.965 to $4.93 range. That is up +11% on the projected 2040 average. That marks a +183% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NUWE today (≈ 1,319.783555 NUWE) could be worth
$2,830.15
+$1,830.15 (+183%) by 2050 · US Dollar
Based on the average projected NUWE price of $2.14 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NUWEwould be worth at today's price.
$1,000 invested in NUWE on May 27, 2025 (≈ 26.752273 NUWE) would be worth
$20.27
-$979.73 (-98.0%) today · 0.02× · US Dollar
Based on a NUWE entry price of $37.38 vs. today's $0.7577.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.99 | $765.35 | -23.5% |
| 1 month ago | $1.16 | $653.19 | -34.7% |
| 3 months ago | $1.6 | $473.56 | -52.6% |
| 6 months ago | $2.44 | $310.53 | -68.9% |
| 1 year ago | $37.38 | $20.27 | -98.0% |
| All time (5.0y) ago | $648,270 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NUWE forecast.
Our base-case forecast reaches $1.50 around 2040.
Implied market cap at $1.50: $4.02M
Looking across the multi-year forecast, NUWE shows a mix of neutral and bullish periods with notable upside potential. In 2027 the avg is $1.12 with a 47.4% ROI, moving higher in 2028 to an avg of $1.08 and a 42.2% ROI, and in 2029 to an avg of $1.05 with a 38.9% ROI. By 2030 the avg is $0.9231 with a 21.8% ROI, and 2031 sits at an avg of $0.8455 with an 11.6% ROI, before resuming gains in 2032 (avg $1.06; ROI 40%), 2033 (avg $1.30; ROI 71.3%), 2034 (avg $1.35; ROI 78.2%), and 2035 (avg $1.27; ROI 68.1%).
The outlook remains bullish for 2040 (avg $1.93; ROI 155%) and 2050 (avg $2.14; ROI 183%), with max forecast values reaching $4.12 in 2040 and $4.93 in 2050. These figures imply meaningful upside over the long run, though some years show flatter, more modest gains and neutral sentiment. These are estimates, not guarantees, and should be weighed against the risks inherent in small-cap healthcare equities.
Tap a question to reveal the answer.
In 2030, NUWE is forecast to have a min of $0.5829, an avg of $0.9231, and a max of $1.57, with an ROI of 21.8%.
The forecast shows a neutral stance in 2026 and bullish tones in several following years, with an average price movement toward $0.92 by 2030 and up to $2.14 by 2050, and max prices up to $4.93. However, these are estimates and not guarantees, and risks exist in this small-cap healthcare stock.
Yes. The forecast lists a max of $4.12 in 2040 and $4.93 in 2050, indicating potential to reach or exceed $4 in the long term.
The current price is $0.7577.
The 30-day price range is from $0.5453 to $1.05.
Nuwellis, Inc. Community Discussion
0Share your Nuwellis, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.